July 16, 2024
Loading...
You are here:  Home  >  Banking & Finance  -  Page 338

Montecito Bank & Trust
Latest

PCBC reports $70.5M in 2011 profits

By   /  Monday, January 30th, 2012  /  Banking & Finance, Banking Industry, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on PCBC reports $70.5M in 2011 profits

[wikichart align=”center” ticker=”PCBC” showannotations=”true” livequote=”true” rollingdate=”6 months” width=”390″ height=”245″] Pacific Capital Bancorp, the largest bank based in the region, earned $70.5 million in 2011, its first full calendar year under the ownership of a Texas-based private equity group. The parent company of Santa Barbara Bank & Trust saw its fourth-quarter profits drop 39.8 percent to Read More →

Latest

Under scrutiny, First California targets South Coast

By   /  Friday, January 27th, 2012  /  Banking & Finance, Banking Industry, Top Stories, Tri-County Public Companies  /  Comments Off on Under scrutiny, First California targets South Coast

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Big California banks see 2011 earnings bounce

By   /  Friday, January 27th, 2012  /  Banking & Finance, Banking Industry, Personal Finance, Top Stories  /  Comments Off on Big California banks see 2011 earnings bounce

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Ceres to debut at $21 to $23 per share

By   /  Thursday, January 26th, 2012  /  Banking & Finance, Latest news, Tri-County Public Companies  /  Comments Off on Ceres to debut at $21 to $23 per share

Thousand Oaks-based energy crop developer Ceres has plans to make its debut on the Nasdaq on Feb. 8 under the symbol CERE and raise $132 million. Shares in the company, which uses genetic marking technology to speed the development of non-food energy crops such as drought-resistant switchgrass, are expected hit the markets at between $21 Read More →

Latest

Amgen Q4 earnings drop 8.5%

By   /  Thursday, January 26th, 2012  /  Banking & Finance, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Amgen Q4 earnings drop 8.5%

[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Biotech giant Amgen, which said earlier on Thursday that it would pay $1.2 billion for leukemia drugmaker Micromet, reported fourth-quarter earnings that missed analyst expectations. The Thousand Oaks-based company said fourth-quarter profits fell 8.5 percent to $934 million, or $1.08 per share, on lower sales of Read More →

Latest

First California reports record 2011 earnings of $23.4M

By   /  Thursday, January 26th, 2012  /  Banking & Finance, Banking Industry, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on First California reports record 2011 earnings of $23.4M

[wikichart align=”right” ticker=”NASDAQ:FCAL” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Westlake Village-based First California Financial Group reported profits of $23.4 million in 2011, a company earnings record. A year earlier, it had earned $1.4 million. “Our record breaking performance in 2011 was driven by the combination of continued successful execution of our strategic plan that focuses Read More →

Latest

Amgen to pay $1.2B for cancer drug firm

By   /  Thursday, January 26th, 2012  /  Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen to pay $1.2B for cancer drug firm

[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-07-2011″ enddate=”26-01-2012″ width=”300″ height=”245″] Thousand Oaks-based Amgen is buying a leukemia drug maker for $1.2 billion in a bid to boost its blockbuster drug lineup. Amgen, the world’s largest biotech company, said Jan. 26 that it will purchase Maryland-based Micromet, maker of an experimental leukemia drug. Investors of Microment will Read More →